Skip to Main content Skip to Navigation
Journal articles

Oncolytic Virotherapy for human malignant mesothelioma: recent advances

Abstract : Cancer virotherapy is an attractive alternative to conventional treatments because it offers a wide range of antitumor effects due to 1) the diversity of the oncolytic viruses that are now available and 2) their multifaceted activities against both tumor cells and tumor vessels, in addition to their ability to induce antitumor immune responses. In this review, we summarize preclinical and clinical data regarding the targeting of malignant mesothelioma (MM) by oncolytic viruses. We also discuss the potential of other oncolytic viruses that have already shown antitumor effects against several malignancies in advanced clinical trials but are yet to be tested against MM cells. Finally, we review how the activation of the immune system and combinations with other types of anticancer treatments could support the development of oncolytic virotherapy for the treatment of MM.
Document type :
Journal articles
Complete list of metadatas

Cited literature [72 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01285355
Contributor : Elizabeth Bernardo <>
Submitted on : Wednesday, March 9, 2016 - 9:53:33 AM
Last modification on : Friday, June 19, 2020 - 3:08:45 AM
Long-term archiving on: : Sunday, November 13, 2016 - 12:07:53 PM

Files

OV-66091-oncolytic-virotherapy...
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Nicolas Boisgerault, Carole Achard, Laurent Cellerin, Frédéric Tangy, Marc Grégoire, et al.. Oncolytic Virotherapy for human malignant mesothelioma: recent advances. Oncolytic Virotherapy, DovePress, 2015, ⟨10.2147/OV.S66091⟩. ⟨inserm-01285355⟩

Share

Metrics

Record views

455

Files downloads

1259